Table 1: Baseline characteristics of enrolled CVID patients, data shown for all patients (All) and patients with negative (-) vs. positive (+) values of anti-GAD (>0.9 kU/mL), anti-TPO (>60 kU/mL) autoantibodies respectively, medians (SD, maximu – minimum) are displayed, the differences between particular groups unsignificant (p >0.05).